Terms: = Bone cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
243 results:
1. Donor
Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
[TBL] [Abstract] [Full Text] [Related]
2. Allogeneic CAR-T cells with of hla-a/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies.
Chen X; Tan B; Xing H; Zhao X; Ping Y; Zhang Z; Huang J; Shi X; Zhang N; Lin B; Cao W; Li X; Zhang X; Li L; Jiang Z; Zhang M; Li W; Liu M; Du B; Zhang Y
Cancer Immunol Immunother; 2024 Jan; 73(1):13. PubMed ID: 38231412
[TBL] [Abstract] [Full Text] [Related]
3. The Possible Role of Matrix Metalloprotienase-2 in the Relapse in Patients with Stage II Colon cancer Treated by Curative Surgery.
Murray NP; Villalon R; Aedo S; Hartmann D; Rodriguez MP
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3373-3379. PubMed ID: 37898840
[TBL] [Abstract] [Full Text] [Related]
4. A Web-Based Calculator to Predict Early Death Among Patients With bone Metastasis Using Machine Learning Techniques: Development and Validation Study.
Lei M; Wu B; Zhang Z; Qin Y; Cao X; Cao Y; Liu B; Su X; Liu Y
J Med Internet Res; 2023 Oct; 25():e47590. PubMed ID: 37870889
[TBL] [Abstract] [Full Text] [Related]
5. C-reactive protein impairs immune response of CD8
Jiang J; Peng Z; Wang J; Chen M; Wan Y; Huang H; Liu Z; Wang J; Hou J
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37844994
[TBL] [Abstract] [Full Text] [Related]
6. hla-a*02:06 allele may be susceptible to myelodysplastic syndrome in Zhejiang Han population, China.
Chen N; Wang F; Zhao Y; Dong L; Wang W; Zhang W; He J; Zhu F
Int J Immunogenet; 2023 Oct; 50(5):233-242. PubMed ID: 37485595
[TBL] [Abstract] [Full Text] [Related]
7. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Bolaños-Meade J; Hamadani M; Wu J; Al Malki MM; Martens MJ; Runaas L; Elmariah H; Rezvani AR; Gooptu M; Larkin KT; Shaffer BC; El Jurdi N; Loren AW; Solh M; Hall AC; Alousi AM; Jamy OH; Perales MA; Yao JM; Applegate K; Bhatt AS; Kean LS; Efebera YA; Reshef R; Clark W; DiFronzo NL; Leifer E; Horowitz MM; Jones RJ; Holtan SG;
N Engl J Med; 2023 Jun; 388(25):2338-2348. PubMed ID: 37342922
[TBL] [Abstract] [Full Text] [Related]
8. Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies.
Fatobene G; Mariano L; Volt F; Moreira F; Conelissen J; Furst S; Daguindau E; Sirvent A; Peffault de Latour R; Rafii H; Rivera-Franco MM; Kenzey C; Scigliuolo GM; Cappelli B; Ruggeri A; Gluckman E; Rocha V
Blood Adv; 2023 Jul; 7(13):3297-3306. PubMed ID: 36877784
[TBL] [Abstract] [Full Text] [Related]
9. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.
Olson TS; Frost BF; Duke JL; Dribus M; Xie HM; Prudowsky ZD; Furutani E; Gudera J; Shah YB; Ferriola D; Dinou A; Pagkrati I; Kim S; Xu Y; He M; Zheng S; Nijim S; Lin P; Xu C; Nakano TA; Oved JH; Carreno BM; Bolon YT; Gadalla SM; Marsh SG; Paczesny S; Lee SJ; Monos DS; Shimamura A; Bertuch AA; Gragert L; Spellman SR; Babushok DV
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36219480
[TBL] [Abstract] [Full Text] [Related]
10. Impact of human leukocyte antigen mismatch on outcomes after unrelated bone marrow transplantation in paediatric patients: A retrospective analysis by the JSTCT HLA working group.
Kato I; Sakaguchi H; Kato S; Sato M; Noguchi M; Yoshida N; Koh K; Koike T; Yanagimachi M; Kato K; Takahashi Y; Fujita N; Sato A; Hashii Y; Tabuchi K; Atsuta Y; Morishima S; Kanda J
Br J Haematol; 2022 Nov; 199(3):392-400. PubMed ID: 36029121
[TBL] [Abstract] [Full Text] [Related]
11. Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant.
Jimenez Jimenez A; Komanduri K; Brown S; Wang T; Pereira D; Goodman M; Beitinjaneh A; Lekakis L; Chinapen S; Devlin S; Ponce D; Sauter C; Perales MA; Shaffer BC
Blood Adv; 2022 Aug; 6(15):4491-4500. PubMed ID: 35793451
[TBL] [Abstract] [Full Text] [Related]
12. Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy.
Hasan AN; Doubrovina E; Sottile R; Prockop S; Klatt MG; Heller G; Selvakumar A; Barnett L; Hsu KC; O'Reilly RJ
Blood Adv; 2022 Aug; 6(16):4859-4872. PubMed ID: 35605246
[TBL] [Abstract] [Full Text] [Related]
13. HLA alleles and haplotype frequencies in Iranian population.
Ghafouri-Fard S; Hussen BM; Pashmforoush S; Akbari MT; Arsang-Jang S; Nazer N; Hamidieh AA; Hajifathali A; Dinger ME; Sayad A; Dehaghi MO
Hum Antibodies; 2022; 30(2):79-96. PubMed ID: 35342084
[TBL] [Abstract] [Full Text] [Related]
14. CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.
Ruggiero E; Carnevale E; Prodeus A; Magnani ZI; Camisa B; Merelli I; Politano C; Stasi L; Potenza A; Cianciotti BC; Manfredi F; Di Bono M; Vago L; Tassara M; Mastaglio S; Ponzoni M; Sanvito F; Liu D; Balwani I; Galli R; Genua M; Ostuni R; Doglio M; O'Connell D; Dutta I; Yazinski SA; McKee M; Arredouani MS; Schultes B; Ciceri F; Bonini C
Sci Transl Med; 2022 Feb; 14(631):eabg8027. PubMed ID: 35138911
[TBL] [Abstract] [Full Text] [Related]
15. Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10
Blumenschein GR; Devarakonda S; Johnson M; Moreno V; Gainor J; Edelman MJ; Heymach JV; Govindan R; Bachier C; Doger de Spéville B; Frigault MJ; Olszanski AJ; Lam VK; Hyland N; Navenot JM; Fayngerts S; Wolchinsky Z; Broad R; Batrakou D; Pentony MM; Sanderson JP; Gerry A; Marks D; Bai J; Holdich T; Norry E; Fracasso PM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086946
[TBL] [Abstract] [Full Text] [Related]
16. Adding Help to an hla-a*24:02 Tumor-Reactive γδTCR Increases Tumor Control.
Johanna I; Hernández-López P; Heijhuurs S; Scheper W; Bongiovanni L; de Bruin A; Beringer DX; Oostvogels R; Straetemans T; Sebestyen Z; Kuball J
Front Immunol; 2021; 12():752699. PubMed ID: 34759930
[TBL] [Abstract] [Full Text] [Related]
17. Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody.
Augsberger C; Hänel G; Xu W; Pulko V; Hanisch LJ; Augustin A; Challier J; Hunt K; Vick B; Rovatti PE; Krupka C; Rothe M; Schönle A; Sam J; Lezan E; Ducret A; Ortiz-Franyuti D; Walz AC; Benz J; Bujotzek A; Lichtenegger FS; Gassner C; Carpy A; Lyamichev V; Patel J; Konstandin N; Tunger A; Schmitz M; von Bergwelt-Baildon M; Spiekermann K; Vago L; Jeremias I; Marrer-Berger E; Umaña P; Klein C; Subklewe M
Blood; 2021 Dec; 138(25):2655-2669. PubMed ID: 34280257
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells.
Álvarez-Palomo B; García-Martinez I; Gayoso J; Raya A; Veiga A; Abad ML; Eiras A; Guzmán-Fulgencio M; Luis-Hidalgo M; Eguizabal C; Santos S; Balas A; Alenda R; Sanchez-Gordo F; Verdugo LP; Villa J; Carreras E; Vidal F; Madrigal A; Herrero MJ; Rudilla F; Querol S
Stem Cell Res Ther; 2021 Apr; 12(1):233. PubMed ID: 33849662
[TBL] [Abstract] [Full Text] [Related]
19. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.
Nishida T; Kobayashi T; Sawa M; Masuda S; Shibasaki Y; Goto T; Fukuhara N; Fujii N; Ikegame K; Sugita J; Ikeda T; Kuwatsuka Y; Suzuki R; Najima Y; Doki N; Kato T; Inagaki Y; Utsu Y; Aotsuka N; Masuko M; Terakura S; Onishi Y; Maeda Y; Okada M; Teshima T; Murata M
Ann Hematol; 2021 Mar; 100(3):743-752. PubMed ID: 33427909
[TBL] [Abstract] [Full Text] [Related]
20. Use of the HLA-B leader to optimize cord blood transplantation.
Petersdorf EW; Gooley T; Volt F; Kenzey C; Madrigal A; McKallor C; Querol S; Rafii H; Rocha V; Tamouza R; Chabannon C; Ruggeri A; Gluckman E
Haematologica; 2021 Dec; 106(12):3107-3114. PubMed ID: 33121238
[TBL] [Abstract] [Full Text] [Related]
[Next]
